Dr. Tuohy will join the company's Dublin office and will bring strategic thinking and in-depth knowledge of the international clinical trials landscape to further expand Cromos™ Pharma's operations amidst its growing geographic presence. "Cromos™ Pharma continues to grow at a fast pace and we are very excited to see Dr. Tuohy joining our team," said Dr. Vlad Bogin, Cromos™ Pharma's CEO. "We have made significant progress in expanding our operations and attracting clients that look for expeditious, cost-efficient and high quality clinical research. With the addition of Dr. Tuohy we are positioning the company to bring high-value solutions to new and existing clients," Dr. Bogin continued.
"It is a privilege to be joining the Cromos team and I look forward to contributing to the business development activities and to building increased market share in areas where Cromos holds significant commercial advantages," added Dr. Tuohy. "Cromos™ Pharma has a solid differentiated business model of rapid clinical trial execution and a lean operational structure coupled with meticulous attention to quality. With Cromos' team I believe there are several additional market opportunities that may be exploited in the near to mid-term."
Dr. Tuohy has over two decades of experience in translational medicine and business development in the life sciences industry. Prior to joining Cromos™ Pharma he served as Principal with Ibla Partners, a niche life sciences company delivering professional business services in clinical trial management and new technology development. Prior to Ibla, Dr. Tuohy held senior positions in both academic and commercial organizations in which he built novel technologies and valuable investment opportunities in the fields of neurodegeneration, cardiovascular disease and drug delivery. He has been a founder and executive in several high technology businesses and has served at all stages of business development from initial venture funding through to M&A exit.
About Cromos™ Pharma
Cromos™ Pharma, LLC is a contract research organization (CRO) with operations in the post-Soviet space and in Eastern/Central Europe. The company provides a full spectrum of trial-related services which include clinical monitoring, regulatory approvals, medical writing, feasibility assessments, project management and warehousing. Cromos™ Pharma, LLC is a privately owned company.
Ukraine, the eight largest European country by population, is an attractive location for sponsors conducting clinical research for a number of key reasons. Cromos Pharma has been successfully managing clinical trials in Ukraine since 2006. This article looks at just some of the benefits of locating your next study here.
Cromos Pharma is continuously developing and looking to explore new territories when it comes to clinical research. In line with this spirit of discovery, we will be shortly commencing a new project in Uzbekistan supporting a study being conducted by the Swiss Tropical and Public Health Institute.
Cromos Pharma is delighted to be taking part in the upcoming DIA Europe conference (15 – 19 March 2021) and BIO-Europe Spring (22-25 March 2021).
February 11th is International Women and Girls in Science Day. A joint UNESCO and UN-Women initiative, it aims to promote the role of #WomenInScience and to challenge some of the barriers to girls pursuing a career in science.
Are you a sponsor seeking to conduct clinical trials in the European Union but do not have a registered office in the European Economic Area? If so, in order to comply with the European Union Clinical Trial Directive, you are required to work with a Legal Representative registered in an EEA country.
Each 4th February, #WorldCancerDay aims to raise awareness of the global personal, social and economic burden of cancer. World Cancer Day was established in Paris at the first World Cancer Summit in 2000.
As 2021 begins, many countries are grappling with a renewed surge of COVID-19 infections necessitating further public health restrictions putting more pressure on health systems, societies and global economies. The task of rolling out approved vaccines is increasingly urgent. Almost 16 million doses of COVID-19 vaccines have been administered to date in 37 countries worldwide according to data compiled by Bloomberg ( updated 7 Jan 2021).
Tuesday 1 December marked World AIDS Day 2020. Although throughout this year our focus has been on the coronavirus pandemic, World AIDS Day is an opportunity to reflect on another pandemic where a virus passed from animals to humans with devastating consequences. To date 77 million people worldwide have been infected with HIV. In spite of innovative new treatments 35 million people have died from the virus.
If you missed the live webinar “Where in the world should I locate my pivotal clinical trial?” you can now watch the recording by clicking here. The webinar hosted by the Society of Physician Entrepreneurs (SoPE) and Workforce Genetics features Cromos Pharma's CEO Vlad Bogin, M.D, FACP.